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Although the dorsal raphe nucleus (DRN) has long been linked to neural control of aggression, little is known about the regulatory
influences of the DRNwhen an animal engages in either adaptive species-typical aggressive behavior or escalated aggression. Therefore
it is important to explorewhichneurotransmitter inputs into theDRNdetermine the escalationof aggression inmalemice. Previously,we
observed that microinjection of the GABAB receptor agonist baclofen into the DRN escalates aggressive behavior in male mice. Here, we
used a serotonin (5-HT) neuron-specific GABAB receptor knock-out mouse to demonstrate that baclofen acts on nonserotonergic neu-
rons to escalate aggression. Intra-DRN baclofen administration increased glutamate release, but did not alter GABA release, within the
DRN. Microinjection of L-glutamate into the DRN escalated dose-dependently attack bites toward an intruder. In vivo microdialysis
showed that glutamate release increased in the DRN during an aggressive encounter, and the level of glutamate was further increased
when the animalwas engaged in escalated aggressive behavior after social instigation. Finally, 5-HT releasewas increasedwithin theDRN
and also in the medial prefrontal cortex when animals were provoked by social instigation, and during escalated aggression after social
instigation, but this increase in 5-HT release was not observed when animals were engaged in species-typical aggression. In summary,
glutamate input into theDRN is enhancedduring escalated aggression,which causes aphasic increaseof 5-HTrelease fromtheDRN5-HT
neurons.
Key words: dorsal raphe nucleus; escalated aggression; GABAB receptor; glutamate; serotonin (5-HT); species-typical aggressive behavior
Introduction
The dorsal raphe nucleus (DRN) contains the largest accumula-
tion of serotonin (5-HT) cell bodies in the brain, and it sends
efferent projections to several distinct targets including the limbic
structures and cortex (Hale and Lowry, 2011). Previous studies
have identified neural activity in theDRN to be critical for aggres-
sive behavior in several mammalian species (Jacobs and Cohen,
1976;Walletschek andRaab, 1982; Vergnes et al., 1986;Mos et al.,
1993; Koprowska andRomaniuk, 1997; van der Vegt et al., 2003),
and 5-HT is the neurotransmitter which has been most strongly
implicated in aggression (Coccaro et al., 1997; Kravitz and Hu-
ber, 2003; de Boer and Koolhaas, 2005; Miczek et al., 2007). The
activity of serotonergic neurons in the DRN is modulated by
5-HT itself, as well as byGABA, glutamate, and other neurotrans-
mitters (Adell et al., 2002). In contrast to the long-standing focus
on 5-HT systems in the control of aggression, little is known
about how the DRN 5-HT system is modulated when animals
engage in species-typical or escalated aggression.
Previously, we have shown that pharmacological activation of
GABAB receptors, but not GABAA receptors, in the DRN en-
hanced territorial aggression in male mice (Takahashi et al.,
2010a,b). This manipulation caused animals to engage in longer
aggressive bursts and to direct more attack bites at vulnerable
body areas of male intruders (Takahashi et al., 2012). The DRN
expresses high levels of GABAB receptors (Bischoff et al., 1999),
and almost all 5-HT neurons express GABAB receptors (Wirt-
shafter and Sheppard, 2001; Burman et al., 2003; Serrats et al.,
2003). Electrophysiology and microdialysis studies have demon-
strated that the application of the GABAB receptor agonist
baclofen in the DRN inhibits 5-HT neurons (Tao et al., 1996;
Judge et al., 2004). However, other studies, including our own,
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have shown that intra-DRN baclofen microinjections increased
5-HT release in the DRN and in projection areas, such as the
dorsal striatum or medial prefrontal cortex (mPFC) (Abella´n et
al., 2000; Takahashi et al., 2010b). Furthermore, the aggression-
heightening effects of baclofen depend on the activation of 5-HT
neurons in the DRN because these effects were blocked by coad-
ministration of the 5-HT1A agonist 8-OH-DPAT, which acts on
somatodendritic autoreceptors and inhibits 5-HT neural activity
(Takahashi et al., 2010b).We hypothesized that the proaggressive
effect of baclofen was mediated via GABAB receptors on nonse-
rotonergic neurons within the DRN, which enhanced 5-HT
neurotransmission.
In the present study, we first showed that baclofen acts on
nonserotonergic neurons within the DRN to escalate aggression.
The DRN receives glutamatergic input from many brain areas,
such as mPFC and lateral habenula (Celada et al., 2001; Varga et
al., 2003; Challis et al., 2013). Our results indicate that glutama-
tergic input to the DRN is critical for the escalation of aggression,
induced by either pharmacological (baclofen) or behavioral (so-
cial instigation)means. Finally, we found that the enhanced input
of glutamate in the DRN during escalated aggression, but not
during species-typical aggression, led to increased 5-HT release
in both the DRN and mPFC.
Materials andMethods
Animals.Male mice, aged 8–9 weeks at the beginning of aggression tests,
were used as resident males (except 9–11 weeks for Experiment 1). Con-
ditional knock-out mice on the C57BL/6J background were used for
Experiment 1 (see details in the next section) and ICR/Jcl mice (CLEA
Japan) for the other experiments (Table 1). Each resident male was pair-
housed with a female (C57BL/6JJcl females for Experiment 1 and ICR/Jcl
females for Experiments 3–9) for 3 weeks before the beginning of aggres-
sion tests in a polycarbonate cage (22 32 13.5 cm) with wood chips
as bedding material. In Experiment 1, C57BL/6JJcl males (CLEA Japan),
aged 7–9 weeks, bred and maintained at the National Institute of Genet-
ics (NIG), were used as intruders. For Experiments 3–9, male ICR/Jcl
mice were used as intruders, aged 5–8 weeks at the beginning of aggres-
sion test, and instigators, aged 12–15 weeks. Intruder males and instiga-
tormales were housed in groups of five to seven per cage (22 32 13.5
cm) with wood chips. Experiments 1–3, and 5–9 were conducted during
the dark period at the NIG with controlled humidity and temperature
(50 10%, 23 2°C) on a 12 h light/dark cycle (lights off at 6:00 P.M.).
Experiment 4 was conducted at the University of Tsukuba during the
same dark period (23  2°C, 12 h light/dark cycle, lights off at noon).
Separate sets of animals were used for each experiment. Food and water
were available ad libitum. All procedures were performed with approval
from the Committee for Animal Care and Use of the NIG (permit nos.
23-10, 24-10, and 25-10) and the Animal Care andUse Committee at the
University of Tsukuba (permit no. 14-391).
Mice with a 5-HT neuron-specific deletion of GABAB receptors (Experi-
ment 1).AconditionalGABABreceptoralleleinmice(GABAB1
lox511/lox511)was
developedat theUniversityofBasel (Haller et al., 2004), and then backcrossed
into C57BL/6J over 10 generations at Nagoya University. The 5-HT
transporter (5-HTT)-Cre transgenic (Tg208) mouse expressing the Cre
recombinase under the control of putative 5-HTT promoter in the
RP23–39F11 BAC clone (Mizuno et al., 2014) was generated at
RIKEN BSI (Arakawa et al., 2014, Suzuki et al., 2015). This mouse was
generated and has been maintained on a C57BL/6J genetic back-
ground. GABAB1
lox511/lox511 and 5-HTT-Cre mice were crossed at the
NIG to obtain GABAB1
/lox511;5-HTT-Cre mice. Subsequently, we
crossed thesemice toGABAB1
lox511/lox511mice to yieldGABAB1
lox511/lox511;
5-HTT-Cre mice (referred to as 5-HTT-GABAB1
/ or conditional
knock-out (cKO)mice in this paper) andGABAB1
lox511/lox511;5-HTT-Cre
mice (wild-type control littermates;WT).Genotypingwas conductedbefore
weaning using ear punch samples.
Histology and immunostaining. To examine the expression of Cre pro-
tein in 5-HTT-Cre mice, we crossed 5-HTT-Cre mice with RNZ mice
that in the presence of Cre protein express a nuclear localization signal-
lacZ transgene inserted in theRosa26 locus (Kobayashi et al., 2013). At 10
weeks of age, mice were deeply anesthetized with pentobarbital (97.4
mg/kg somnopentyl; Kyoritsu Seiyaku) and intracardially perfused with
0.9% saline followed by Zamboni solution (4%paraformaldehydemixed
with 0.2% picric acid in PBS, pH 7.0). After postfixation in Zamboni
solution for 2 h, brains were cryoprotected in 30% sucrose and frozen at
80°C. A cryostat was used to slice the brains into 40msections, which
were stored at20°Cuntil staining. To examine the colocalization of Cre
Table 1. Animals used in this study
Experiment Strain of resident Intruder Drug Total animals used for analysis Excluded
1 Intra-DRN baclofen 5-HTT GABAB1
/
cKO (C57BL/6J
background)
C57BL/6J Baclofen (0.6, 0.3 nmol) or aCSF 11 WT and 12 cKO 8 missed placement, 3 stop
fight, 2 dead
2 Glutamate and GABAmicrodialysis
in the DRN during baclofen
administration
ICR — Baclofen (0.6 nmol) or aCSF 9 4 missed placement
3 Intra-DRN L-glutamate ICR ICR L-glutamate (0.1, 1M) or aCSF 10 1 stop fight
4 Antagonism of L-glutamate by
APV NBQX
ICR ICR 1M L-glutamate with/without
50M APV 10M NBQX,
or saline
11 3 stop fight, 6 missed
placement
5 Glutamate microdialysis in the
DRNduring aggressive encounter
ICR ICR — 11 3missed placement, 2 broken
probe, 1 stop fight, 1 sick
6 Glutamate microdialysis in the
DRN during instigation-height-
ened aggression
ICR ICR — 10 1missed placement, 1 stop
fight, 3 mechanical
problem
7 5-HT microdialysis in the DRN
during aggressive encounter
ICR ICR — 11 3missed placement
8 5-HT microdialysis in the DRN
during instigation-heightened
aggression
ICR ICR — 11 1missed placement
9 5-HT microdialysis in the mPFC
during aggressive encounter and
instigation-heightened
aggression
ICR ICR — 9 (1 animal without-instigation
only)
1 damaged brain, 1 mechani-
cal problem
Takahashi et al. • Glutamate in Dorsal Raphe Escalates Aggression J. Neurosci., April 22, 2015 • 35(16):6452–6463 • 6453
protein with 5-HT neurons, we examined the expression of tryptophan
hydroxylase (Tph) and a product of LacZ gene, -galactosidase (-Gal),
in themidbrain area. After 1 h of incubationwith a blocking solution (5%
normal goat serum, 0.2% Triton X-100) at room temperature (RT),
sections were incubated with a mixture of primary antibodies (1:1000
mouse polyclonal anti-Tph antibody; T0678, Sigma-Aldrich), and
1:1000 rabbit anti--Gal polyclonal antibody (AB1211, Millipore) in the
blocking solution overnight at 4°C. After washing with PBS, the sections
were incubated with a mixture of secondary antibodies conjugated to
DyLight (anti-mouse DyLight 549 and anti-rabbit DyLight 488, both
1:400, Jackson ImmunoResearch Laboratories). Slides were coverslipped
with Fluoromount (Diagnostic BioSystems) and microscopic analysis
was done with a fluorescent microscope (Zeiss Axio Imager M1). To
confirm lack of GABAB receptor-protein expression in DRN serotoner-
gic neurons of 5-HTT-GABAB1
/ mice, we double-stained for Tph
(1:500, sheep polyclonal anti-tryptophan hydroxylase antibody AB1541,
Millipore) and GABAB1 (1:300, mouse monoclonal anti-GABAB1 anti-
body ab55051, Abcam) in cKO and control WT mice. The procedure
was the same as described above, with the exception that we used 2%
normal goat serum with 0.5% Triton X-100 as blocking solution and
the secondary antibodies were Alexa labeled (anti-mouse AlexaFluor
488 and anti-sheep AlexaFluor 555, both 1:600, Life Technologies).
At the end of all behavioral and in vivo microdialysis experiments,
experimental mice were deeply anesthetized with pentobarbital and int-
racardially perfused with Zamboni solution, and their brains were re-
moved, cryoprotected with sucrose, frozen, and sliced into 60 m
sections. These slices were stained with cresyl violet to verify the place-
ments of the cannula and the microdialysis probe.
PCR analysis of KO allele. To examine whether Cre-mediated excision
of exonVII andVIII of the GABAB1 receptor gene (Gabbr1) was achieved
in the DRN, four cKO mice and four WT mice were killed and their
brains were removed. The midbrain slice (including both the superior
and inferior colliculi) was hand-dissected on ice, and then the DRN was
dissected by using a 1 mm diameter punch (Harris Uni-Core-1.00, Ted
Pella Inc) from the midbrain slice. The tissue was homogenized in Tris-
EDTA buffer and digested by proteinase K to isolate DNA. PCR was
conducted to detect the floxed allele and the KO allele, using 40 ng of
DNA for each sample. To examine the deletion of the floxed exons VII
andVIII, a primer upstreamof exonVII (P7) and a primer specific for the
loxP site downstream of exon VIII (P8) were used (Haller et al., 2004).
Genotyping to ascertain Cre locus and floxed Gabbr1 locus for the
production and maintenance of experimental animals was performed
using ear punch samples for PCR with other primer sets (Haller et al.,
2004; Iwasato et al., 2004, 2008).
Resident-intruder test and social instigation test before surgery. Each
resident male was housed with a female for 3 weeks before starting any
behavioral experiment to let them establish territory in the homecage.
Then, each resident male was studied for its aggression toward the same
intruder (Miczek and O’Donnell, 1978). The female and pups were re-
moved right before the test, and then an intruder was introduced into the
homecage of the resident male. Their behavior was recorded for 5 min
after the first bite, or the intruder was removed after 5 min if no attack
occurred. For Experiment 1, eight aggressive encounters, one every other
day, were conducted to determine whether the presence or intensity of
aggression differed between cKOandWTmice. For Experiments 3 and 4,
aggressive encounters occurred once every other day until the animals
showed a stable number of attack bites (variation among the last three
encounters 20% after 8–16 encounters), after which cannulation sur-
gery was performed. For Experiments 5 and 7, resident males experi-
enced aggressive encounters six times every other day before surgery to
confirm that they showed reliable aggressive behavior. In the rare in-
stances when the intruder started to attack the resident male or the resi-
dent did not show any aggressive behavior for three to four consecutive
encounters, we replaced the intruder.
The social instigation procedure was implemented as previously de-
scribed (Fish et al., 1999). Briefly, a sexually mature naivemale instigator
mouse was placed inside a protective wire mesh cylinder (8 cm diame-
ter  10 cm height), where it could be seen, heard, and smelled by the
resident male. The shielded instigator was placed in the middle of the
resident’s homecage for 10 min. Immediately after removal of the insti-
gator from the resident’s homecage, an intruder male was introduced
and the 5 min resident-intruder test was conducted. For Experiments 6,
8, and 9, all residentmales first experienced resident-intruder testing five
times every other day. The residents were then characterized in terms of
their aggressive behavior with and without social instigation as assessed
by conducting twice a resident-intruder test and a social instigation test
separated by a 1 d interval in alternation. All tests were performed during
the dark period (6:00–11:00 P.M.) under dim red lights.
Cannulation and drug microinjection test (Experiments 1, 3, and 4).
Resident males were anesthetized by intraperitoneal injection of a mix-
ture of 100mg/kg ketamineHCl and 10mg/kg xylazine. A 26 gauge guide
cannula (Plastics One) was stereotaxically implanted 1.5 mm above the
DRN (AP, 4.6 mm; ML, 1.5 mm; DV, 1.9 mm to bregma; angled
26° to the vertical) as calculated from a mouse brain atlas (Franklin and
Paxinos, 2008). A 33 gauge obdurator (Plastics One) the same length as
the guide cannula was inserted after surgery. The obdurator was moved
every other day to prevent blockage and scarring and also to habituate the
animals to handling. Animals were housed individually for 5 d to recover,
and then their female and pups were returned into the homecage. One
week after the surgery, aggressive behavior was re-established using three
resident-intruder tests performed every second day, before starting
microinjections.
During drug microinjection, the obdurator was removed and a 33
gaugemicroinjector (PlasticsOne) extending 1.5mmbelow the tip of the
guide was inserted into the guide cannula to reach the DRN. The micro-
injectorwas connected to a 1l Hamilton syringe placed into an infusion
pump (ESP-32; Eicom) via PE 50 tube. The drug was infused in a volume
of 0.2l over 2min, and themicroinjectorwas left in place for 1min after
the infusion to allow the drug to diffuse completely. Ten minutes after
the microinjection, a resident-intruder test was conducted, and the ag-
gressive interactions were recorded for 5 min after the first attack bite. In
Experiment 1, an animal received a total of four microinjections: 0.06
nmol baclofen, 0.3 nmol baclofen, and artificial CSF (aCSF) vehicle
twice. In Experiment 3, an animal received a total of four microinjec-
tions: 0.1M L-glutamate, 1M L-glutamate, and aCSF vehicle twice. The
dose of L-glutamate was determined by a pilot study which tested doses
from1M to 50mM. In Experiment 4, each animal received a total of four
microinjections: 1 M L-glutamate, a combination of 1 M L-glutamate
and the mixture of 10 M NBQX plus 50 M APV, and twice vehicle.
Drugs were administered in a semi-random order in each experiment.
Drugs. Baclofen [()--(aminomethyl)-4-chlorobenzenepropanoic
acid], L-glutamate, NBQX (NBQX disodium salt), and APV (D-(-)-2-
amino-5-phosphonovaleric acid) were purchased from Wako Pure
Chemical Industries. Drugs were dissolved in either aCSF (Experiments
1–3) or saline (Experiment 4).
In vivo microdialysis
Extracellular glutamate and GABA in the DRN after baclofen treatment
(Experiment 2). In this experiment, we used MI-A-4-01 microdialysis
probes (Eicom) which combine a 1mm activemembrane and a 34 gauge
drug microinjector. The tip of the drug microinjector is located right
beside the top of the active membrane, thus making it possible to mea-
sure the effect of drug application on neurotransmitter release within the
DRN. Males were anesthetized with a mixture of ketamine HCl (100
mg/kg) and xylazine (10 mg/kg) and were then implanted with a MI-A-
4-01 probe into the DRN (AP,4.6 mm; ML,1.5 mm; DV,2.4 mm
to bregma; angled 26° to the vertical) in the morning (10:00–11:00
A.M.). After surgery, animals were placed in the test cage (19 29 20
cm) with bedding material from the homecage, food, and hydration gel.
The probe was perfused with aCSF at a flow rate of 0.5 l/min using a
microsyringe pump (ESP-64; Eicom). Two hours before the beginning of
the dark phase (at 4:00 P.M.), the flow rate was increased to 2l/min and
a 40l samplewas collected every 20min during the dark period by using
a microfraction collector (EF-80, Eicom) cooled with ice. Six samples
were collected to measure the baseline level of GABA and glutamate in
the DRN. Then, 0.2l aCSF was microinfused into the DRN over 2 min.
One hour after the aCSF injection, 0.06 nmol of baclofen was microin-
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jected into theDRNand samples were collected continuously for another
2 h. Microdialysates were stored at80°C until HPLC analysis.
Extracellular glutamate measurement in the DRN during aggressive be-
havior and social instigation (Experiments 5 and 6). After resident males
were tested for both species-typical aggression without social instigation
and social instigation-heightened aggression, they were implanted with a
CXG-6 guide cannula (Eicom) aimed just above the DRN (DRN: AP,
4.6 mm; ML, 1.5 mm; DV, 2.4 mm to bregma; angled 26° to the
vertical) under ketamine-xylazine anesthesia. After surgery, males were
housed individually without females, because some females damaged the
microdialysis guide cannulae before the test. After 1 week of recovery,
resident-intruder encounters were conducted to check whether residents
still fought after the surgery. In themorning of the test day, animals were
anesthetized with isoflurane and a CX-I-6-01 microdialysis probe (Ei-
com)with 1mmactivemembrane was inserted into the guide cannula to
reach the DRN. Animals were then placed in the test cage (19 29 20
cm) with bedding material from their homecage. The probe was first
perfused with aCSF at a flow rate of 0.5l/min; at 4:00 P.M. the flow was
increased to 2 l/min. After 2 h of stabilization, 20 l samples were
collected every 10 min in the dark period. In Experiments 5 and 6, five
samples were first collected to measure the baseline level of glutamate in
the DRN. Then, in Experiment 5, an intruder male was placed in the test
cage for 2 min while the resident male’s aggressive behavior was video-
taped. In Experiment 6, an instigator in a protective cage was placed in
the middle of the test cage for 10 min, and then an intruder male was
introduced for a 2 min videotaped encounter. Microdialysate was con-
tinuously collected for 1 h during and after the aggressive encounters,
and samples were stored at80°C until HPLC analysis.
Extracellular 5-HTmeasurement in the DRN during aggressive behavior
and social instigation (Experiments 7 and 8). The test procedure was sim-
ilar to Experiments 5 and 6, except that the flow rate during samplingwas
1 l/min. Every 10 min the microdialysate sample was immediately in-
jected into the HPLC by an auto injector (EAS-20, Eicom). Five samples
were collected tomeasure the baseline level of 5-HT in theDRN. Then, in
Experiment 7, an intrudermalewas placed in the test cage for 2minwhile
the resident male’s aggressive behavior was videotaped. In Experiment 8,
an instigator in a protective cage was placed in the middle of test cage for
10min, and then an intrudermale was introduced for a 2min videotaped
encounter.
Extracellular 5-HT measurement in the mPFC during aggressive behav-
ior (Experiment 9). After resident males were characterized in terms of
their aggressive behavior, they were implanted a CXG-6 guide cannula
(Eicom) aimed above the mPFC (AP, 2.0 mm; ML, 0.3 mm; DV,
0.3 mm to bregma) under ketamine-xylazine anesthesia. The test pro-
cedure was similar to other microdialysis experiments, except that the
active membrane of the probe was 2 mm and the same resident male
experienced both species-typical aggression test (without social instiga-
tion) and social instigation-heightened aggression test. At the beginning
of the dark phase (6:00 P.M.), five samples were collected to measure the
baseline level of 5-HT in the mPFC. Then, an intruder male was intro-
duced and stayed for 2 min in the test cage where the resident male’s
aggressive behavior was videotaped. Approximately 2 h later, a caged
instigator male was placed in the test cage for 10 min, followed by the
introduction of an intruder male for 2 min with videotaping.
HPLC analysis. Microdialysate samples were assayed using a HPLC
system equipped with an electrochemical detector (ECD-300, Eicom)
and ODS columns: EICOMPAK SC-50DS (3.0 mm ID  150 mm, Ei-
com) at 30°C for GABA and glutamate, and EICOMPAC PP-ODS II (4.6
mm ID  30 mm, Eicom) at 25°C for 5-HT. To measure GABA and
glutamate, dialysates were derivatized with one-third volume of ortho-
phthalaldehyde-2-mercaptoethanol (OPA-2ME; containing 4 mM
ortho-phtalaldehyde, 0.2% 2-mercaptoethanol, 100 mM potassium car-
bonate, and 10% ethanol) for 2.5min. Differentmobile phases were used
to measure GABA and glutamate: 25 mM PBS, pH 2.8, 13.4 M EDTA-
2Na and 50% methanol for GABA, and 70 mM PBS, pH 6, 13.4 M
EDTA-2Na and 30% methanol for glutamate. In Experiment 2, each
microdialysate sample was split into two to measure both GABA (24 l)
and glutamate (9l) concentrations. For the analysis of glutamate release
during aggressive behavior (Experiments 5 and 6), 18 l of microdialy-
sate sample was used for glutamate measurement. To measure 5-HT
(Experiments 7–9), a mobile phase with 100 mM PBS, pH 5.4, 500 mg/L
SDS, 13.4 M EDTA-2Na, and 2%methanol was used, and the whole 10
min microdialysate samples (10 l) were injected automatically. The
changes in the GABA, glutamate, and 5-HT concentrations were ex-
pressed as the percentage change from the average baseline samples for
each individual.
Statistics. Detailed behavioral analysis of the videotaped resident-
intruder tests was conducted by a trained observer to quantify aggressive
behaviors (i.e., attack bites, sideways threats, pursuits, tail rattles) and
nonaggressive behaviors (i.e., walking, rearing, auto-grooming, contacts;
Grant and Mackintosh, 1963; Miczek and O’Donnell, 1978). The occur-
rence of these behaviors was recorded by using free software established
by A. Tanave (TanaMove0.07). The frequency of attack bites and the
duration of all other operationally defined behaviors were analyzed.
For Experiment 1, repeated-measures two-way ANOVA was con-
ducted to examine the effect of genotype and session on attack bites
before the surgery (WT: n 17, cKO: n 19). To examine the effect of
baclofen, repeated-measures two-way ANOVA was performed to exam-
ine the effect of genotype and drug treatment on aggressive and nonag-
gressive behaviors in WT (n  11) and 5-HTT-GABAB1
/ cKO mice
(n  12), and Tukey-Kramer post hoc test was used (  0.05). In this
experiment, there were four missing data values, two data points (1 WT
and 1 cKO) for 0.06 nmol baclofen and two data values (1 WT and 1
cKO) for 0.3 nmol baclofen. Those values were substituted with the
average value of each genotype for the corresponding dose for statistical
analysis, and the degrees of freedom were adjusted. For Experiments 3
and 4, repeated-measures one-way ANOVA was performed to examine
the effect of the intra-DRN microinjection of L-glutamate and
L-glutamate with APVNBQX on aggressive and nonaggressive behav-
iors. Tukey-Kramer test was conducted as a post hoc analysis to determine
which doses of the drug differed significantly from vehicle ( 0.05).
For the in vivo microdialysis, repeated-measures one-way ANOVA
was performed for all data; 15 data values for Experiment 2 (6 base line
samples, three samples after the aCSFmicroinfusion, and 6 samples after
the baclofenmicroinfusion), 11 data values for Experiments 5, 7, and 9 (5
base line samples, and 6 samples during and after aggressive encounter),
and 12 data values for Experiments 6, 8, and 9 (5 base line samples, one
social instigation, and 6 samples during and after aggressive encounter).
If the F valuewas significant, Tukey-Kramer post hoc tests (Experiment 2)
or t tests with Bonferroni correction (Experiments 6–9) were conducted
to compare an average baseline value to each subsequent sample ( 
0.05).
Results
Baclofen acts at GABAB receptors on non-5-HT neurons to
escalate aggression
We first examined the role of GABAB receptors on 5-HT neurons
in relation to escalated aggressive behavior by using a 5-HT
neuron-specific GABAB receptor cKO mouse. The cKO mice
were generated by crossing a floxed GABAB1 mouse with a
5-HTT-Cre (Tg208) mouse. To examine the expression pattern
of Cre protein in the midbrain of 5-HTT-Cre mouse, we crossed
5-HTT-Cre mouse to RNZ reporter mice, which express
-galactsidase (-Gal) in Cre-positive cells. Immunostaining of
Tph and -Gal showed that 95.6% of Cre-positive neurons were
5-HT neurons in the midbrain area (both Tph and -Gal-posi-
tive: 1341 cells, Tph only: 82 cells,-Gal only: 62 cells; Fig. 1A–F).
Although the Cre is also expressed in the thalamic sensory relay
nuclei in 5-HTT-Cre mice (Arakawa et al., 2014; Suzuki et al.,
2015), our current data showed that Cre protein was preferen-
tially expressed on the 5-HT neurons in the case of midbrain area
where baclofen was locally administered. A 5-HTT-Cre mouse
was then crossed with a floxed GABAB1 mouse to obtain 5-HT
neuron-specific GABAB receptor cKO mice. PCR analysis
showed that the tissue punch of the DRN area in the cKO mice
showed both knock-out allele and WT allele, whereas the other
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midbrain area had only theWT allele (Fig. 1G). Immunostaining
for Tph and GABAB1 showed a strong expression of GABAB re-
ceptors on Tph-positive DRN neurons in the WT (Fig. 1H–K),
but cKO mice rarely express GABAB receptor on Tph-positive
neurons (Fig. 1L–O).
Before the cannulation surgery, the level of aggressive behav-
ior in the cKO mice was comparable to that of WT littermates
(Fig. 1P). Repeated-measures two-way ANOVA showed that
there was no main effect of genotype on aggressive behavior over
eight encounters. After cannulation, we examined their aggres-
sion after microinjecting either baclofen (0.06 or 0.3 nmol) or
aCSF into the DRN. Repeated-measures two-way ANOVA
showed that there were significant main effects of baclofen on all
aggressive behaviors including attack bites (F(2,42) 12.646, p
0.0001), sideways threats (F(2,42) 11.333, p 0.0001), tail rat-
tles (F(2,42)  9.380, p  0.0004), and pursuits (F(2,42)  7.293,
p  0.0019), and baclofen increased these behaviors in a dose-
dependent manner (Fig. 1Q; Table 2). There was neither a signif-
icant main effect of genotype nor any genotype  drug
interaction on any aggressive or nonaggressive behaviors. How-
ever, post hoc t tests showed that when cKO mice were treated
with 0.06 nmol baclofen they showed a significant increase in
attack bites compared with their basal level, whereas WT mice
showed a smaller, nonsignificant increase at this dose (Fig. 1I).
The higher dose (0.3 nmol) caused significant increases in attack
bite frequency in both groups. Repeated-measures two-way
Figure 1. Escalated aggression induced by intra-DRN baclofen in the conditional knock-out mouse of GABAB receptor on 5-HT neurons. 5-HTT-Cre mouse expresses Cre protein in Tph-positive
5-HT raphe neurons in themidbrain (A–F ). Immunostaining of Tph (A,D; Sigma-Aldrich, anti-Tph 1:1000) and-gal (B, E; Millipore, anti--gal 1:1000), and colocalization of Tph and-gal (C, F )
in the DRN of 5-HTT-Cre mice crossed with RNZ reporter mice with 10 (A–C) and 40 (D–F ) magnification. G, PCR analysis showed that 5-HT neuron-specific GABAB receptor cKOmice (n 4)
possessed KO allele aswell as floxed allele (lox511) in the DRNpuncture,whereas only floxed allelewas detected inmidbrain leftover sample.WTmice (n 4) showed only floxed allele in both DRN
and midbrain sample. Immunohistochemistry confirmed the deletion of GABAB receptor expression on Tph-positive 5-HT neurons in cKO mice (L–O) in comparison with WT mice (H–K ).
Immunostaining of Tph (H, L) (Millipore, anti-Tph 1:500) and GABAB receptor (I,M; Abcam, anti-GABAB receptor 1, 1:300) and colocalization of Tph and GABA B receptor (J,K,N,O) with 10 (H–J,
L–N ) and20 (K,O)magnification.P, Frequency of attack bites in cKOand itsWT littermatedidnot differ before the surgery andat the vehicle injection into theDRN.Q, Effect of intra-DRNbaclofen
on attack bites behavior in cKO and WT littermate. Both cKO and WT littermate showed significant increase of attack bites by 0.3 nmol baclofen from its aCSF level, whereas 0.06 nmol baclofen
significantly increased attack bites only in cKO mice. Data are mean SEM expressed as percentage change from vehicle; *p 0.05 compared with its vehicle control within the genotype.
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ANOVAs also found significant main effects of baclofen on some
nonaggressive behaviors including walking (F(2,42) 10.686, p
0.0002), rearing (F(2,42)  6.060, p  0.0049), and grooming
(F(2,42)  5.312, p  0.0088). The highest dose of baclofen (0.3
nmol) significantly increased walking and reduced rearing and
grooming (Table 2) due to the induction of stereotypic turning as
a side effect. To summarize, the deletion of GABAB receptors in
5-HTneurons hadno effect on the aggression-heightening effects
of intra-DRN baclofen. Rather, cKOmice showed slightly higher
sensitivity to the proaggressive effect of baclofen than WT mice.
We conclude that the site of action for baclofen’s escalation of
aggressive behaviormust be theGABAB receptors onnonserotoner-
gic neurons. Our previous studies showed a significant increase in
aggressive behavior by intra-DRN administration of baclofen in
ICR/Jcl strain (Takahashi et al., 2010b, 2012), and current study
replicated the aggression-heightening effect of baclofen in a
C57BL/6J background strain. However, the effective dose seems to
differ between strains. ICR/Jcl showeda significant increase of attack
biteswith amoderatedoseof baclofen (0.06nmol),whereas ahigher
dose (0.3 nmol) was required for C57BL/6J mice.
Baclofen increases glutamate, but not GABA, release in
the DRN
In the DRN, GABAB receptors are localized on GABA interneu-
rons and also the terminals of glutamatergic projections (Bagdy
et al., 2000; Soiza-Reilly et al., 2013). If baclofen acts on these
presynaptic or interneuronal GABAB receptors in the DRN, we
can predict that the release of GABA and/or glutamate will be
reduced by baclofen administration. To examine the effect of an
aggression-heightening dose of baclofen (0.06 nmol for ICR
strain; Takahashi et al., 2010b, 2012) on the synaptic release of
GABA and glutamate within theDRN, wemeasured extracellular
GABA and glutamate concentrations in the DRN using in vivo
microdialysis. Microinjection of 0.06 nmol baclofen into the
DRN did not change GABA release in the DRN (Fig. 2A). In
contrast, we found that baclofen significantly increased the level
of extracellular glutamate (F(14,112) 2.687, p 0.0020; Fig. 2B).
A significant increase in glutamate was observed in the first 20
min sample, after which the level of glutamate returned to its
basal level. Therewas no effect of aCSF injectionon either glutamate
or GABA release in the DRN (Fig. 2A,B). At present, it is unknown
howexactly thisunexpected increase inglutamateas a resultof intra-
DRN baclofen was achieved. Nonetheless, we interpret the increase
of glutamate in the DRN in conjunction with our microinjection
data as being relevant to baclofen-heightened aggression.
Direct injection of L-glutamate into the DRN enhances
aggressive behavior
Next, we asked whether the increase of glutamate input in the
DRNplays any role in the aggressive behavior ofmalemice. Thus,
we examined the effect of direct injection of L-glutamate into the
DRN on aggressive behavior. Either L-glutamate (0.1 M or 1.0
M) or aCSF was microinjected into the DRN of ICR resident
male mice and their aggressive behavior was examined 10 min
after the injection. We found that L-glutamate significantly in-
creased attack bites in a dose-dependentmanner (F(2,18) 4.609,
p  0.0242), and post hoc tests showed a significant increase in
attack bites after microinjecting 1.0 M glutamate into the DRN
(Fig. 3A). L-glutamate also had a significant effect on tail-rattle
behavior (F(2,18)  3.768, p  0.0429), and 0.1 M L-glutamate
significantly reduced tail rattles (Table 3). L-glutamate tended to
dose-dependently increase other aggressive behaviors (sideways
threats and pursuits), but these effects did not reach statistical
significance. L-glutamate had no effect on nonaggressive behav-
iors, such as walking or rearing (Table 3). Preliminary data
showed that the higher concentration of glutamate (100Mor 10
mM) did not increase attack bites (data not shown); thus, gluta-
mate in the DRN produced an inverted U-shape dose-effect rela-
tionship with regard to attack bites.
To examine the involvement of ionotropic glutamate recep-
tors on this aggression-heightening effect of L-glutamate, the an-
tagonist mixture (APVNBQX) was coinjected with 1.0 M
L-glutamate into the DRN of male mice (Fig. 3B). Repeated mea-
sures one-way ANOVA showed a significant main effect of drug
on attack bites (F(2,20)  5.751, p  0.0106), sideways threat
(F(2,20)  4.846, p  0.0192), tail rattles (F(2,20)  4.846, p 
0.0192), as well as walking (F(2,20) 3.923, p 0.0365). Post hoc
tests showed that microinjection of L-glutamate significantly in-
creased aggressive behaviors including attack bites, sideways
threat, and tail rattles compared with saline control. Coinjection
of APVNBQX with L-glutamate did not significantly increase
any aggressive behaviors from vehicle, and there were significant
reductions of attack bites and sideways threat in coinjection
group compared with L-glutamate group (Fig. 3B; Table 4).
Therefore, antagonism of ionotropic glutamate receptors
blocked the aggression-heightening effect of L-glutamate.
Increased glutamate input in the DRN during aggressive
encounter and further increase during escalated aggression
To examine whether the increase in glutamate input within the
DRN occurs during aggressive behavior in the absence of phar-
macological intervention, we measured the extracellular gluta-
mate level in the DRN while animals were engaging in aggressive
behavior (Fig. 4A, top). We found that the level of extracellular
glutamate in the DRN increased during the aggressive encounter
(F(10,100)  2.057, p  0.0351), and post hoc tests identified a
significant increase in glutamate in the first 10min sample (Fig. 4B).
To determine whether or not increased physical activity during the
Table 2. Effect of intra-DRN baclofen on aggressive and nonaggressive behaviors in
5-HTTGABAB1
/ (cKO) mice
aCSF Baclofen 0.06 nmol Baclofen 0.3 nmol
Attack bites
WT 20.5 2.9 32.9 3.6 43.9 7.3*
cKO 15.7 2.7 41.2 7.9* 34.5 6.5*
Sideways threats (s)
WT 12.0 1.8 23.8 3.5* 24.8 5.8*
cKO 8.8 2.0 28.8 6.5* 21.6 5.8
Tail rattles (s)
WT 18.0 3.7 33.1 7.3 37.6 9.0
cKO 11.8 3.4 27.2 6.6* 32.9 7.4*
Pursuits (s)
WT 6.7 2.6 10.3 2.9 26.6 9.7*
cKO 4.7 2.3 15.2 5.1 15.9 4.8
Walking (s)
WT 73.5 5.5 74.9 7.8 113.1 19.9
cKO 80.5 5.7 72.0 6.6 125.5 21.9
Rearing (s)
WT 16.3 3.3 11.5 3.3 7.3 2.3
cKO 19.8 3.9 13.1 4.1 9.1 3.0
Self-grooming (s)
WT 29.2 8.7 28.2 4.9 14.1 4.8
cKO 32.2 7.5 23.5 4.7 12.8 3.9*
Social contact (s)
WT 22.0 8.5 15.9 3.9 20.3 7.5
cKO 18.2 4.8 14.3 3.6 20.4 4.8
All values are mean SEM; *p 0.05 compared with aCSF.
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aggressive encounter caused the increased
glutamate input in the DRN, we examined
the correlation between locomotor activity
andextracellularglutamate in theDRNdur-
ing six baseline samples. Our preliminary
data showed that there was no correlation
between extracellular glutamate and loco-
motor activity (n  2, r2  0.14 and r2 
0.04 each). Therefore, the increase of gluta-
mate release in theDRNwas induced specif-
ically by aggressive behavior.
To examine whether or not the escala-
tion of aggressive behavior corresponds to
further increases of glutamate input in the
DRN, we examined the level of extracellu-
lar glutamate during heightened aggres-
sion induced by social instigation, a
behavioral procedure to provoke aggres-
sive behavior of male rodents (Fish et al.,
1999; Fig. 4A, bottom). Test animals were
examined for their aggression with and
without social instigation, and we con-
firmed that the social instigation proce-
dure significantly increased the frequency
of attack bites compared with aggressive
encounters without social instigation be-
fore the surgery (t(33)  7.404, p 
0.0001; Fig. 4C), and during in vivomicro-
dialysis (t(46)  2.692, p  0.0099; Fig.
4D). Repeated-measures one-way
ANOVA showed that there was a signifi-
cant change in extracellular glutamate in
the DRN (F(9,99)  9.168, p  0.0001),
and significant increases of glutamate
were observed both during the social
instigation and for 20 min after the ag-
gressive encounter (Fig. 4E). Glutamate
tended to remain elevated for up to 1 h after the aggressive
encounter, but after 20 min the differences were no longer
statistically significant. The increase in glutamate levels during
aggressive behavior tended to be higher in instigation-
heightened aggression (166%) compared with that of species-
typical aggression (143%), so glutamate levels were positively
correlated with the level of aggression.
5-HT release in the DRN andmPFC increased during
escalated, but not during species-typical, aggression
Because excitatory glutamate input was increased in the DRN of
resident male mice during aggressive behavior, it is possible that
the 5-HT release in the DRN and in its projection areas was
increased by this glutamate input. Thus, we examined the 5-HT
release in the DRN during aggressive encounters of resident male
mice. There was no significant main effect of sample time on
extracellular 5-HT in the DRN, and we did not observe any
change in 5-HT levels during the first 10min sampling period that
included the 2 min aggressive encounter (Fig. 5A). We then exam-
ined the 5-HT release in the DRN during social instigation and
instigation-heightened aggression (Fig. 5B) and found a significant
main effect of sample time on extracellular 5-HT in the DRN
(F(11,121)  7.318, p  0.0001). There were significant increases of
5-HT release in the DRN both during 10 min of social instigation
and also during the subsequent escalated aggression.
To examine the change of 5-HT release in one of the projec-
tion sites, we then inserted a 2 mm microdialysis membrane
probe into themPFC.We first examined the 5-HT release during
species-typical aggression (without instigation), and again there
was nomain effect of sample time on extracellular 5-HT concen-
tration in the mPFC (Fig. 5C). By contrast, when we measured
5-HT release during social instigation and subsequent
instigation-heightened aggression, we observed a significant
main effect of sample time on 5-HT in themPFC (F(7,77) 4.076,
p 0.0001; Fig. 5D). There were trends toward increases in 5-HT
during the social instigation period, and during and after the
instigation-heightened aggression but the increases did not reach
statistical significance due to large variance.
Discussion
Glutamate is an important mediator of baclofen-heightened
aggression in the DRN
Previously, we showed that microinjection of the GABAB receptor
agonist baclofen into the DRN escalated aggression in male mice,
both quantitatively and qualitatively (Takahashi et al., 2010b, 2012).
Because this effect of baclofen depends on the activation of 5-HT
neurons in theDRN (Takahashi et al., 2010b), we hypothesized that
the aggression-heightening effect of baclofen was mediated by
GABAB receptors on nonserotonergic neurons. In this study, we
demonstrated that genetic deletion of GABAB receptors in 5-HT
neurons did not affect the aggression-heightening effect of intra-
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Figure 2. Extracelluler glutamate and GABA in the DRN of ICR male mice after baclofen injection into the DRN. Baclofen
microinjected into the DRN increased the glutamate (B), but not the GABA (A), level in the DRN, whereas aCSF injection did not
changeeither glutamateorGABA level. Twenty-minute sampleswere collected: six samples for baseline, three samples after saline
injection, and six samples after baclofen (0.06 nmol) injection. Data aremean SEMexpressed as percentage of baseline (n 9);
*p 0.05 compared with baseline.
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DRN baclofen inmale cKOmice, providing further evidence of the
importantroleofGABABreceptormodulationofnonserotonergicneu-
rons inbaclofen-heightenedaggression.Higher sensitivity to theproag-
gressive effect of baclofen in cKOmice indicates that GABAB receptors
on 5-HTneurons have an inhibitory role on aggressive behavior.
In addition to 5-HT neurons, almost all GABAergic neurons,
as well as other types of neurons, such as glutamatergic neurons,
in the DRN express GABAB receptors (Serrats et al., 2003; Soiza-
Reilly et al., 2013). In vitro experiments using rat midbrain slices
have shown that the application of baclofen inhibits glutamate
release and hyperpolarizes 5-HT neurons (Colmers and Wil-
liams, 1988; Soiza-Reilly et al., 2013). On the other hand, in the
ventral tegmental area, lower concentrations of baclofen inhibit
GABA neurons and consequently disinhibit the postsynaptic do-
pamine neurons, whereas higher doses directly inhibit the dopa-
mine neurons (Cruz et al., 2004; Laboue`be et al., 2007). Because
we previously found that an aggression-heightening dose of
baclofen microinjected into the DRN increased the release of
5-HT in the mPFC (Takahashi et al., 2010b), we originally hy-
pothesized that this dose of baclofen preferentially acts on GABA
interneurons and thus reduces GABA input in the DRN which
therefore disinhibits 5-HT neuronal activity. Unexpectedly, our
results showed that an aggression-heightening dose of baclofen in-
creased the glutamate release in the DRN, but did not change the
level of GABA. At present, we do not have an explanation as to how
baclofen could increase extracellular glutamate in the DRN. One
possibility is that baclofen preferentially inhibits some GABA in-
terneurons that modulate glutamatergic terminals, but this reduc-
tion of GABA release was minor compared with net GABA tone in
the DRN, and thus we could not detect this change using in vivo
microdialysis. Another possibility could be the involvement of glial
GABAB receptors, because it has been shown that baclofen increases
Ca2 influx of glia in vitro (Meier et al., 2008), and thus it may be
possible to increase glutamate release from glial cells (Nedergaard et
al., 2002). Analysis of data from conditional knock-out mice that
lack GABAB receptors on either GABA interneurons or glial cells
may allow us to identify the sites of action for baclofen to escalate
aggression. Still, our results conflict with in vitro brain slice studies
that showed a reduction of glutamate release by baclofen applica-
tion. It is possible that macro circuits of several brain areas, which
couldnotbeexamined indissectedbrain slices, are involved in this in
vivo phenomenon. Although the exact site of action for baclofen has
to be clarified in future experiments, our results indicated that the
increase of glutamate input into the DRN caused the escalation of
aggression inmale mice.
Glutamate input in the DRN controls aggressive behavior of
male mice
This study is the first in vivomicrodialysis study to show a change
in glutamate input in the DRN during aggressive behavior in
male mice. We detected a link between the level of glutamate
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Figure 3. Increase of glutamate in the DRN causes escalation of attack bites of male mice. A, Microinjection of L-glutamate into the DRN enhanced the frequency of attack bites with
dose-dependent manner. Values are mean SEM; *p 0.05 compared with vehicle control. B, Coadministration of a mixture of AMPA receptor antagonist NBQX (10M) and NMDA receptor
antagonist APV (50M) blocked the effect of L-glutamate (1M) on frequency of attack bites. L-glutamate itself significantly increased the frequency of attack bites comparedwith vehicle,whereas
L-glutamate did not increase attack bites from its vehicle level when it is coadministered with the antagonist mixture. Values are mean SEM; *p 0.05.
Table 3. Effect of intra-DRN glutamate on aggressive and nonaggressive behaviors
Glutamate (M)
0 0.1 1
Attack bites 29.3 4.1 38.8 4.5 47.4 5.2*
Sideways threats (s) 32.4 4.0 40.2 5.0 42.6 4.8
Tail rattles (s) 25.1 3.2 14.7 2.0* 38.6 10.5
Pursuits (s) 0.3 0.1 0.5 0.3 0.9 0.4
Walking (s) 62.4 5.4 54.2 4.1 57.0 3.1
Rearing (s) 62.3 9.2 47.4 9.8 57.2 10.1
Self-grooming (s) 29.4 6.6 27.5 6.1 25.0 4.4
Social contact (s) 24.2 3.4 27.0 5.2 20.5 2.3
Two doses of L -glutamate were examined. All values are mean SEM. *p 0.05 compared with vehicle.
Table 4. The effect of 1M L -glutamate was antagonized by coadministration of
50M APV 10M NBQX
0 Glutamate Glutamate
0 0 APV NBQX
Attack bites 13.8 3.9 25.1 2.2* 14.5 3.1**
Sideways threats (s) 19.0 4.0 33.8 3.7* 20.9 4.0**
Tail rattles (s) 6.9 1.7 18.2 3.4* 12.3 2.3
Pursuits (s) 0.0 0.0 0.0 0.0 0.0 0.0
Walking (s) 46.4 7.0 45.6 5.6 34.2 4.1
Rearing (s) 58.7 10.1 57.3 10.1 42.0 8.7
Self-grooming (s) 13.7 2.7 24.0 4.1 25.7 6.2
Social contact (s) 26.2 3.8 27.1 8.0 26.6 6.2
All values are mean SEM. *p 0.05 compared with vehicle, **p 0.05 compared with L -glutamate group in
antagonists coinjection group.
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input in theDRNand the level of aggressive behavior, because (1)
direct injection of L-glutamate into the DRN increased intermale
aggression in mice in a dose-dependent manner, and (2) the in-
crease of glutamate release in the DRN was higher in the
instigation-heightened aggression than during species-typical ag-
gression without social instigation. Glutamate input in the DRN
also increased during the period of social instigation, where the
mouse can see, hear, and smell another male but cannot perform
any aggressive behavior. Thus, the increase of glutamate in the
DRNcorresponds to both provocation (initiation) and execution
of aggressive behavior. The precise role of this glutamate input as
the basis for the motivational aspects of escalated aggressive be-
havior, as well as its relationship to stress responses, remains to be
clarified in the future.
In the microinjection experiment, we found that the
aggression-heightening effect of L-glutamate showed systematic
dose-dependency in the low-dose range (0.1–1.0 M), but disap-
peared at higher doses (	100 M). The extracellular level of glu-
tamate in rat hippocampus or striatum was estimated1–3 M
in vivo (Lerma et al., 1986; Baker et al., 2002), or 25 nM in vitro
(Herman and Jahr, 2007). In our study, the basal extracellular
glutamate concentration in themouseDRNwas estimated0.31
M ( 0.16 M), and it increased during the aggressive behavior
to 0.46 M ( 0.22 M). Therefore, the effective dose range of
L-glutamate on aggressive behavior in our study was very close to
the physiological range of glutamate in the DRN. Although it is
known that excessive levels of glutamate can induce excitotoxic-
ity and induce cellular necrosis or apoptosis (Bonfoco et al.,
1995), the doses of L-glutamate that had proaggressive effects in
our study were much lower than the doses that may have neuro-
toxic effects (20 M; Iriyama et al., 2009).
Differences in 5-HT release between species-typical
aggression and escalated aggression
Previous studies showed that in male rats, 5-HT release in the
mPFC was reduced during the termination of an aggressive en-
counter, and was also reduced in the nucleus accumbens during
anticipation of an aggressive episode (van Erp andMiczek, 2000;
Ferrari et al., 2003). In the present study, 5-HT release in theDRN
and mPFC of male mice did not change during species-typical
aggressive encounters. The difference may be attributable to spe-
cies differences (rat vsmouse) in 5-HT function on aggression. In
addition, our 10 min dialysate sample for each aggressive en-
counter included both the 2 min encounter and an additional 8
min after the aggression ended. Because we found a delayed in-
crease of extracellular 5-HT in the DRN after aggressive encoun-
ters (Fig. 5A), it is possible that a slight reduction of 5-HT during
aggressive behavior may be counterbalanced by an increase in
5-HT release afterward or vice versa. In any case, these results
indicate that there is either a reduction or no change of 5-HT
release when rodents engage in species-typical aggression. On the
other hand, when animals engage in escalated aggression, we ob-
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served a significant increase in 5-HT release in both the DRN and
themPFC. This result is consistent with our previous finding that
an aggression-heightening dose of baclofen microinjected into
the DRN caused an increase of 5-HT release in the mPFC (Taka-
hashi et al., 2010b). Thus, in contrast to species-typical aggres-
sion, a phasic increase of 5-HT release seems to be linked to
escalated level of aggression induced by social instigation.
In the present study, a direct injection of L-glutamate into the
DRN escalated aggression, and there was also a significant in-
crease in glutamate in the DRN during instigation-heightened
aggression. These results indicate that an enhancement of gluta-
matergic input into the DRN activates 5-HT neurons, and leads
to escalated aggression in male mice. On the other hand, we also
observed a smaller but still statistically significant increase of glu-
tamatergic input in the DRN during species-typical aggression.
Because 5-HT release was not increased during the same period
of time, it is likely that the glutamate inputs during species-typical
aggression and instigation-heightened aggression are qualita-
tively different. In other words, different sets of glutamatergic
projections into the DRNmay be activated during different types
of aggression. Several brain areas send glutamatergic projections
to the DRN with different topological organization (Lee et al.,
2003; Crawford et al., 2011; Sego et al., 2014). ThemPFC is one of
the areas that send dense glutamatergic projections to the DRN.
The optogenetic activation of the terminals of mPFC excitatory
projections in the DRN activates GABA interneurons, and there-
fore inhibits 5-HT neural activities (Challis et al., 2014). This
pathway has been shown to be involved in the reduction of social
interaction in defeated animals (Challis et al., 2013, 2014). Also,
optogenetic activation of mPFC excitatory neurons can inhibit
aggressive behavior of male mice (Takahashi et al., 2014). Thus,
the effect of glutamatergic input from mPFC on aggressive be-
havior or active social approach seems to be not excitatory, but
rather inhibitory. Many other areas, such as the habenula, hypo-
thalamic areas, extended amygdala, basal ganglia, and periaque-
ductal gray also send glutamatergic input into the DRN (Pin˜eyro
and Blier, 1999, Ogawa et al., 2014). Further study will be re-
quired to dissect which glutamatergic input is linked to species-
typical aggression and escalated aggression.
Some studies have shown that the inhibition of the 5-HT sys-
tem causes an escalation of aggressive behavior (Hendricks et al.,
2003; Mosienko et al., 2012; Audero et al., 2013). On the other
hand, our results indicated that 5-HT release increased when
mice engaged in escalated aggression after social instigation, and
demonstrated that the phasic change of DRN5-HT release differs
depending on the types of aggression. In the future, we plan to
examine which activation pattern or inhibition of the 5-HT sys-
tem can affect which type of aggression.
Notes
Supplemental material for this article is available at http://www.nig.ac.
jp/labs/MGRL/Supplemental Figs1_2.pdf. Supplemental Figure 1 shows
representative pictures of the DRN with baclofen injection (A), with
L-glutamate injection (B), and in vivo microdialysis (C). Also, the repre-
sentative picture of the mPFC with in vivo microdialysis (D). Supple-
mental Figure 2 showsmicroinjection of several doses of L-glutamate into
the DRN on the frequency of attack bites. Values are mean  SEM. p
value by t test was provided for 0.001 mM L-glutamate compared with
vehicle control. This material has not been peer reviewed.
References
Abella´nMT, Jolas T, AghajanianGK,Artigas F (2000) Dual control of dorsal
raphe serotonergic neurons by GABAB receptors: electrophysiological
and microdialysis studies. Synapse 36:21–34. CrossRef Medline
Adell A, Celada P, Abella´n MT, Artigas F (2002) Origin and functional role
of the extracellular serotonin in the midbrain raphe nuclei. Brain Res Rev
39:154–180. CrossRef Medline
Arakawa H, Suzuki A, Zhao S, Tsytsarev V, Lo FS, Hayashi Y, Itohara S,
-50 -40 -30 -20 -10 0 10 20 30 40 50 60
(min)
5-
H
T 
(%
 c
ha
ng
e 
fro
m
 b
as
el
in
e)
Aggressive encounter
A
0
20
40
60
80
100
120
140
160
180
200
-50 -40 -30 -20 -10 0 10 20 30 40 50 60 -50 -40 -30 -20 -10 0 10 20 30 40 50 60 70
(min) (min)
5-
H
T 
(%
 c
ha
ng
e 
fro
m
 b
as
el
in
e)
Aggressive encounter Aggressive encounterInstigation
5-
H
T 
(%
 c
ha
ng
e 
fro
m
 b
as
el
in
e)
C D
0
20
40
60
80
100
120
140
160
180
200
0
20
40
60
80
100
120
140
160
180
200
Species-typical aggression Instigation-heightened aggression
DRN
mPFC
+
-50 -40 -30 -20 -10 0 10 20 30 40 50 60 70
(min)
Aggressive encounter
Instigation
5-
H
T 
(%
 c
ha
ng
e 
fro
m
 b
as
el
in
e)
B
0
20
40
60
80
100
120
140
160
180
200
* * *+ + +
Figure 5. 5-HT release in the DRN and the mPFC evoked by aggressive encounter and instigation-heightened aggression. A, Aggressive encounter without instigation did not change the 5-HT
level in the DRN (n 11). However, therewas delayed increase of 5-HT 10–20min after the aggressive encounter.B, Social instigation caused increases of 5-HT release in the DRN during the social
instigation and during and after the instigation-heightened aggression (n 11). C, There was not change of 5-HT in the mPFC during aggressive encounter without social instigation (n 9). D,
Similar to the DRN, social instigation caused increases of 5-HT release in themPFC during the social instigation and during and after instigation heightened aggression (n 8). Each 10min sample
was collected: five samples for baseline, one sample for during and after aggressive encounter, and five further samples after aggressive encounter for species-typical aggression, subsequent five
samples for base line, one sample for social instigation, one sample for during and after aggressive encounter, and five further samples after aggressive encounter for instigation-heightened
aggression. Data are mean SEM expressed as percentage of baseline; *p 0.05 (with Bonferroni correction),p 0.005 (without Bonferroni correction) compared with baseline.
Takahashi et al. • Glutamate in Dorsal Raphe Escalates Aggression J. Neurosci., April 22, 2015 • 35(16):6452–6463 • 6461
Iwasato T, Erzurumlu RS (2014) Thalamic NMDA receptor function is
necessary for patterning of the thalamocortical somatosensory map and
for sensorimotor behaviors. J Neurosci 34:12001–12014. CrossRef
Medline
Audero E,Mlinar B, BacciniG, SkachokovaZK,Corradetti R,GrossC (2013)
Suppression of serotonin neuron firing increases aggression in mice.
J Neurosci 33:8678–8688. CrossRef Medline
Bagdy E, Kiraly I, Harsing LG Jr (2000) Reciprocal innervation between
serotonergic and GABAergic neurons in raphe nuclei of the rat. Neuro-
chem Res 25:1465–1473. CrossRef Medline
Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW (2002) The origin and
neuronal function of in vivo nonsynaptic glutamate. J Neurosci 22:9134–
9141. Medline
Bischoff S, Leonhard S, Reymann N, Schuler V, Shigemoto R, Kaupmann K,
Bettler B (1999) Spatial distribution of GABA(B)R1 receptor mRNA
and binding sites in the rat brain. J Comp Neurol 412:1–16. CrossRef
Medline
Bonfoco E, KraincD, AnkarcronaM,Nicotera P, Lipton SA (1995) Apopto-
sis and necrosis: two distinct events induced, respectively, by mild and
intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in
cortical cell cultures. Proc Natl Acad Sci U S A 92:7162–7166. CrossRef
Medline
Burman KJ, Ige AO,White JH, Marshall FH, Pangalos MN, Emson PC, Min-
son JB, Llewellyn-Smith IJ (2003) GABAB receptor subunits, R1 and R2,
in brainstem catecholamine and serotonin neurons. Brain Res 970:35–46.
CrossRef Medline
Celada P, Puig MV, Casanovas JM, Guillazo G, Artigas F (2001) Control of
dorsal raphe serotonergic neurons by the medial prefrontal cortex: in-
volvement of serotonin-1A, GABAA, and glutamate receptors. J Neurosci
21:9917–9929. Medline
Challis C, Boulden J, Veerakumar A, Espallergues J, Vassoler FM, Pierce RC,
Beck SG, Berton O (2013) Raphe GABAergic neurons mediate the ac-
quisition of avoidance after social defeat. J Neurosci 33:13978–13988.
CrossRef Medline
Challis C, Beck SG, BertonO (2014) Optogeneticmodulation of descending
prefrontocortical inputs to the dorsal raphe bidirectionally bias socioaf-
fective choices after social defeat. Front Behav Neurosci 8:43. CrossRef
Medline
Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL (1997) Central serotonin
activity and aggression: inverse relationship with prolactin response to
d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.
Am J Psychiatry 154:1430–1435. CrossRef Medline
Colmers WF, Williams JT (1988) Pertussis toxin pretreatment discrimi-
nates between pre- and postsynaptic actions of baclofen in rat dorsal
raphe nucleus in vitro. Neurosci Lett 93:300–306. CrossRef Medline
Crawford LK, Craige CP, Beck SG (2011) Glutamatergic input is selectively
increased in dorsal raphe subfield 5-HT neurons: role of morphology,
topography and selective innervation. Eur J Neurosci 34:1794–1806.
CrossRef Medline
Cruz HG, Ivanova T, Lunn ML, Stoffel M, Slesinger PA, Lu¨scher C (2004)
Bi-directional effects of GABAB receptor agonists on the mesolimbic do-
pamine system. Nat Neurosci 7:153–159. CrossRef Medline
de Boer SF, Koolhaas JM (2005) 5-HT1A and 5-HT1B receptor agonists and
aggression: a pharmacological challenge of the serotonin deficiency hy-
pothesis. Eur J Pharmacol 526:125–139. CrossRef Medline
Ferrari PF, van Erp AM, Tornatzky W, Miczek KA (2003) Accumbal dopa-
mine and serotonin in anticipation of the next aggressive episode in rats.
Eur J Neurosci 17:371–378. CrossRef Medline
Fish EW, FaccidomoS,MiczekKA (1999) Aggression heightened by alcohol
or social instigation in mice: reduction by the 5-HT1B receptor agonist
CP-94,253. Psychopharmacology (Berl) 146:391–399. CrossRef Medline
Franklin K, Paxinos G (2008) The mouse brain in stereotaxic coordinates,
Ed 3. San Diego: Academic.
Grant EC, Mackintosh JH (1963) A comparison of the social postures of
some common laboratory rodents. Behaviour 21:246–259. CrossRef
Hale MW, Lowry CA (2011) Functional topography of midbrain and pon-
tine serotonergic systems: implications for synaptic regulation of seroto-
nergic circuits. Psychopharmacology (Berl) 213:243–264. CrossRef
Medline
Haller C, Casanova E, Mu¨ller M, Vacher CM, Vigot R, Doll T, Barbieri S,
GassmannM, Bettler B (2004) Floxed allele for conditional inactivation
of the GABAB(1) gene. Genesis 40:125–130. CrossRef Medline
HendricksTJ,FyodorovDV,WegmanLJ,LelutiuNB,PehekEA,YamamotoB,Silver
J,WeeberEJ,Sweatt JD,DenerisES (2003) Pet-1ETSgeneplaysacriticalrole in
5-HTneurondevelopmentandisrequiredfornormalanxiety-likeandaggressive
behavior.Neuron 37:233–247.CrossRefMedline
Herman MA, Jahr CE (2007) Extracellular glutamate concentration in hip-
pocampal slice. J Neurosci 27:9736–9741. CrossRef Medline
Iriyama T, Kamei Y, Kozuma S, Taketani Y (2009) Bax-inhibiting peptide
protects glutamate-induced cerebellar granule cell death by blocking Bax
translocation. Neurosci Lett 451:11–15. CrossRef Medline
Iwasato T, Nomura R, Ando R, Ikeda T, TanakaM, Itohara S (2004) Dorsal
telencephalon-specific expression of Cre recombinase in PAC transgenic
mice. Genesis 38:130–138. CrossRef Medline
Iwasato T, Inan M, Kanki H, Erzurumlu RS, Itohara S, Crair MC (2008)
Cortical adenylyl cyclase 1 is required for thalamocortical synapse matu-
ration and aspects of layer IV barrel development. J Neurosci 28:5931–
5943. CrossRef Medline
Jacobs BL, Cohen A (1976) Differential behavioral effects of lesions of the
median or dorsal raphe nuclei in rats: open field and pain-elicited aggres-
sion. J Comp Physiol Psychol 90:102–108. CrossRef Medline
Judge SJ, Ingram CD, Gartside SE (2004) GABA receptor modulation of
5-HT neuronal firing: characterization and effect of moderate in vivo
variations in glucocorticoid levels. Neurochem Int 45:1057–1065.
CrossRef Medline
Kobayashi Y, Sano Y, Vannoni E, Goto H, Suzuki H, Oba A, Kawasaki H,
Kanba S, Lipp HP, Murphy NP, Wolfer DP, Itohara S (2013) Genetic
dissection ofmedial habenula-interpeduncular nucleus pathway function
in mice. Front Behav Neurosci 7:17. CrossRef Medline
Koprowska M, Romaniuk A (1997) Behavioral and biochemical alterations
in median and dorsal raphe nuclei lesioned cats. Pharmacol Biochem
Behav 56:529–540. CrossRef Medline
Kravitz EA, Huber R (2003) Aggression in invertebrates. Curr Opin Neuro-
biol 13:736–743. CrossRef Medline
Laboue`be G, Lomazzi M, Cruz HG, Creton C, Luja´n R, Li M, Yanagawa Y,
Obata K, Watanabe M, Wickman K, Boyer SB, Slesinger PA, Lu¨scher C
(2007) RGS2 modulates coupling between GABAB receptors and GIRK
channels in dopamine neurons of the ventral tegmental area. Nat Neuro-
sci 10:1559–1568. CrossRef Medline
Lee HS, Kim MA, Valentino RJ, Waterhouse BD (2003) Glutamatergic af-
ferent projections to the dorsal raphe nucleus of the rat. Brain Res 963:
57–71. CrossRef Medline
Lerma J, Herranz AS,HerrerasO, Abraira V,Martín del Río R (1986) In vivo
determination of extracellular concentration of amino acids in the rat
hippocampus: a method based on brain dialysis and computerized anal-
ysis. Brain Res 384:145–155. CrossRef Medline
Meier SD, Kafitz KW, Rose CR (2008) Developmental profile and mecha-
nisms of GABA-induced calcium signaling in hippocampal astrocytes.
Glia 56:1127–1137. CrossRef Medline
Miczek KA, O’Donnell JM (1978) Intruder-evoked aggression in isolated
and nonisolated mice: effects of psychomotor stimulants and L-dopa.
Psychopharmacology (Berl) 57:47–55. CrossRef Medline
Miczek KA, Faccidomo S, Fish EW, Debold JF (2007) Neurochemistry and
molecular neurobiology of aggressive behavior. In: Behavioral neuro-
chemistry, neuroendocrinology andmolecular neurobiology (Blaustein J,
ed), pp 285–336. New York: Springer.
Mizuno H, Luo W, Tarusawa E, Saito YM, Sato T, Yoshimura Y, Itohara S,
Iwasato T (2014) NMDAR-regulated dynamics of layer 4 neuronal den-
drites during thalamocortical reorganization in neonates. Neuron 82:
365–379. CrossRef Medline
Mos J,Olivier B, PothM,VanOorschot R, VanAkenH (1993) The effects of
dorsal raphe administration of eltoprazine, TFMPP and 8-OH-DPAT on
resident intruder aggression in the rat. Eur J Pharmacol 238:411–415.
CrossRef Medline
Mosienko V, Bert B, Beis D, Matthes S, Fink H, Bader M, Alenina N (2012)
Exaggerated aggression and decreased anxiety in mice deficient in brain
serotonin. Transl Psychiatry 2:e122. CrossRef Medline
NedergaardM,TakanoT,HansenAJ (2002) Beyond the role of glutamate as
a neurotransmitter. Nat Rev Neurosci 3:748–755. CrossRef Medline
Ogawa SK, Cohen JY, Hwang D, Uchida N, Watabe-Uchida M (2014) Or-
ganization of monosynaptic inputs to the serotonin and dopamine neu-
romodulatory systems. Cell Reports 8:1105–1118. CrossRef Medline
Pin˜eyro G, Blier P (1999) Autoregulation of serotonin neurons: role in an-
tidepressant drug action. Pharmacol Rev 51:533–591. Medline
6462 • J. Neurosci., April 22, 2015 • 35(16):6452–6463 Takahashi et al. • Glutamate in Dorsal Raphe Escalates Aggression
Sego C, Gonc¸alves L, Lima L, Furigo IC, Donato J Jr, Metzger M (2014)
Lateral habenula and the rostromedial tegmental nucleus innervate neu-
rochemically distinct subdivisions of the dorsal raphe nucleus in the rat.
J Comp Neurol 522:1454–1484. CrossRef Medline
Serrats J, Artigas F, Mengod G, Corte´s R (2003) GABAB receptor mRNA in
the raphe nuclei: co-expression with serotonin transporter and glutamic
acid decarboxylase. J Neurochem 84:743–752. CrossRef Medline
Soiza-Reilly M, Anderson WB, Vaughan CW, Commons KG (2013) Pre-
synaptic gating of excitation in the dorsal raphe nucleus by GABA. Proc
Natl Acad Sci U S A 110:15800–15805. CrossRef Medline
Suzuki A, Lee LJ, Hayashi Y, Muglia L, Itohara S, Erzurumlu RS, Iwasato T
(2015) Thalamic adenylyl cyclase 1 is required for barrel formation
in the somatosensory cortex. Neuroscience 290:518–529. CrossRef
Medline
Takahashi A, Kwa C, Debold JF, Miczek KA (2010a) GABAA receptors in
the dorsal raphe´ nucleus of mice: escalation of aggression after alcohol
consumption. Psychopharmacology (Berl) 211:467–477. CrossRef
Medline
Takahashi A, Shimamoto A, Boyson CO, DeBold JF, Miczek KA (2010b)
GABAB receptor modulation of serotonin neurons in the dorsal raphe
nucleus and escalation of aggression inmice. J Neurosci 30:11771–11780.
CrossRef Medline
Takahashi A, Schilit AN, Kim J, Debold JF, Koide T, Miczek KA (2012)
Behavioral characterization of escalated aggression induced by GABAB
receptor activation in the dorsal raphe nucleus. Psychopharmacology
(Berl) 224:155–166. CrossRef Medline
Takahashi A,NagayasuK,NishitaniN,Kaneko S, KoideT (2014) Control of
intermale aggression bymedial prefrontal cortex activation in the mouse.
PLoS One 9:e94657. CrossRef Medline
Tao R, Ma Z, Auerbach SB (1996) Differential regulation of 5-hydroxy-
tryptamine release by GABAA and GABAB receptors in midbrain raphe
nuclei and forebrain of rats. Br J Pharmacol 119:1375–1384. CrossRef
Medline
van der Vegt BJ, Lieuwes N, van de Wall EH, Kato K, Moya-Albiol L,
Martínez-Sanchis S, de Boer SF, Koolhaas JM (2003) Activation of sero-
tonergic neurotransmission during the performance of aggressive behav-
ior in rats. Behav Neurosci 117:667–674. CrossRef Medline
van Erp AM, Miczek KA (2000) Aggressive behavior, increased accumbal
dopamine, and decreased cortical serotonin in rats. J Neurosci 20:9320–
9325. Medline
VargaV, Kocsis B, Sharp T (2003) Electrophysiological evidence for conver-
gence of inputs from themedial prefrontal cortex and lateral habenula on
single neurons in the dorsal raphe nucleus. Eur J Neurosci 17:280–286.
CrossRef Medline
Vergnes M, Depaulis A, Boehrer A (1986) Parachlorophenylalanine-
induced serotonin depletion increases offensive but not defensive aggres-
sion in male rats. Physiol Behav 36:653–658. CrossRef Medline
WalletschekH, RaabA (1982) Spontaneous activity of dorsal raphe neurons
during defensive and offensive encounters in the tree-shrew. Physiol Be-
hav 28:697–705. CrossRef Medline
Wirtshafter D, Sheppard AC (2001) Localization of GABAB receptors in
midbrain monoamine containing neurons in the rat. Brain Res Bull 56:
1–5. CrossRef Medline
Takahashi et al. • Glutamate in Dorsal Raphe Escalates Aggression J. Neurosci., April 22, 2015 • 35(16):6452–6463 • 6463
